{
    "doi": "https://doi.org/10.1182/blood.V116.21.301.301",
    "article_title": "Resequencing Analysis of the Human Candidate Ras and Receptor Tyrosine Kinase Gene Family In Multiple Myeloma ",
    "article_date": "November 19, 2010",
    "session_type": "Myeloma - Biology and Pathophysiology, excluding Therapy: Genomic and Proteomic Profiling",
    "abstract_text": "Abstract 301 Multiple myeloma (MM) is an incurable B-cell malignancy characterized by the clonal proliferation and accumulation of malignant plasma cells in the bone marrow. Despite the growing number of sequencing studies, the comprehensive view of somatic mutations in multiple myeloma is far from clear. One of the most frequently altered gene families in most human cancer is the Ras and the tyrosine kinase (TK) genes, which encode for important regulators of various signal transduction pathways. To uncover the somatic mutation profile of Ras gene and TKs in myeloma, we performed a systematic mutation screening from a selected group of 10 candidate genes in 42 primary myeloma patients. The candidate gene selections were based on the highly altered genes extracted from GEO data sets using Function Express, a data mining and viewer for microarray data. The sequencing of the entire gene region including the promoter and the 3`UTR was performed in the Genome sequencing center at Washington University medical center using the standard resequencing pipeline, from the design of the primers to data output. These data were analyzed with a clinical resequencing pipeline and visualized using the Mutation Viewer software (MV v5.1). We identified 24 nonsynonymous alterations in five genes ( KRAS2, PIK3CA, INSR, LTK and MERTK ) in our myeloma cohort ( Table 1 ). In particular, we identified the previously reported pathogenic mutation in a KRAS gene and novel somatic mutations in the Kinase family (PIK3CA) that would be expected to cause structural changes. We assessed the frequency plots of the known variants and most but not all are significantly different from the normal data set. The overall results suggest that the germline genetic background besides the somatically acquired mutations may exert an important influence on the prognosis and outcome of the myeloma patient. Our genome-wide resequencing approach thus revealed previously known and novel oncogenic mutations in multiple myeloma, but its relevance needs to be considered in the context of other genetic abnormalities. Table 1: DNA alterations in candidate ras and TK genes in primary multiple myeloma  Gene . Gene ID a . Nucleotide change b . Amino acid change . Zygosity c . PolyPhen . COSMIC . KRAS2 3845 c.35 G>A p.G12D Hetero P. Dam Yes KRAS2 3845 c.34 G>T, c.33 T>C p.G12C, A11A Hetero Benign Yes KRAS2 3845 c.183 A>C p.Q61H Hetero P. Dam Yes KRAS2 3845 c.186_194 del p.E62_Y64 Homo   PIK3CA 5290 c.928 C>T p.R310C Hetero  Yes PIK3CA 5290 c.1173 A>G p.I391M Hetero Benign  INSR 3643 c.356 C>T p.A119V Hetero   INSR 3643 c.2243 C>T p.S748L Hetero   INSR 3643 c.3034 G>A p.V1012M Hetero P. Dam  LTK 4058 c.125 G>A p.R42Q Hetero Benign  LTK 4058 c.680 C>T p.P227L Hetero   LTK 4058 c.728 G>A p.R243Q Hetero   LTK 4058 c.1603 G>A p.D535N Hetero   MERTK 10461 c.60 A>T p.R20S Hetero Benign  MERTK 10461 c.1552 A>G p.I518V Hetero, Homo Benign  MERTK 10461 c.1397 G>A p.R466K Hetero, Homo Benign  MERTK 10461 c.353 G>A p.S118N Hetero, Homo Benign  MERTK 10461 c.2608 G>A p.V870I Hetero Benign  MERTK 10461 c.844 G>A p.A282T Hetero Benign  MERTK 10461 c.1493 A>G, c.1494 C>T p.N498S Hetero Benign  MERTK 10461 c.878 G>A p.R293H Hetero Benign  MERTK 10461 c.2593 C>T p.R865W Hetero P. Dam  MERTK 10461 c.2069 C>T p.T690I Hetero Benign  MERTK 10461 c.2467 G>C p.E823Q Hetero Benign  Gene . Gene ID a . Nucleotide change b . Amino acid change . Zygosity c . PolyPhen . COSMIC . KRAS2 3845 c.35 G>A p.G12D Hetero P. Dam Yes KRAS2 3845 c.34 G>T, c.33 T>C p.G12C, A11A Hetero Benign Yes KRAS2 3845 c.183 A>C p.Q61H Hetero P. Dam Yes KRAS2 3845 c.186_194 del p.E62_Y64 Homo   PIK3CA 5290 c.928 C>T p.R310C Hetero  Yes PIK3CA 5290 c.1173 A>G p.I391M Hetero Benign  INSR 3643 c.356 C>T p.A119V Hetero   INSR 3643 c.2243 C>T p.S748L Hetero   INSR 3643 c.3034 G>A p.V1012M Hetero P. Dam  LTK 4058 c.125 G>A p.R42Q Hetero Benign  LTK 4058 c.680 C>T p.P227L Hetero   LTK 4058 c.728 G>A p.R243Q Hetero   LTK 4058 c.1603 G>A p.D535N Hetero   MERTK 10461 c.60 A>T p.R20S Hetero Benign  MERTK 10461 c.1552 A>G p.I518V Hetero, Homo Benign  MERTK 10461 c.1397 G>A p.R466K Hetero, Homo Benign  MERTK 10461 c.353 G>A p.S118N Hetero, Homo Benign  MERTK 10461 c.2608 G>A p.V870I Hetero Benign  MERTK 10461 c.844 G>A p.A282T Hetero Benign  MERTK 10461 c.1493 A>G, c.1494 C>T p.N498S Hetero Benign  MERTK 10461 c.878 G>A p.R293H Hetero Benign  MERTK 10461 c.2593 C>T p.R865W Hetero P. Dam  MERTK 10461 c.2069 C>T p.T690I Hetero Benign  MERTK 10461 c.2467 G>C p.E823Q Hetero Benign  a Gene ID at National center for biotechnology information ( http://www.ncbi.nlm.nih.gov/sites/entrez ) b del., deletion c Homo, homozygous; hetero, heterozygous View Large Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "genes",
        "multiple myeloma",
        "receptor protein-tyrosine kinases",
        "c-mer tyrosine kinase",
        "insulin receptor",
        "cancer",
        "amino acids",
        "dna",
        "nucleotides",
        "phosphotransferases"
    ],
    "author_names": [
        "Vishwanathan Hucthagowder, PhD",
        "Chelsea D. Mullins, BSci",
        "Rekha Meyer, PhD",
        "Rakesh Nagarajan, MD, PhD",
        "John F. DiPersio, MD, PhD",
        "Ravi Vij, MBBS, MD",
        "Michael H. Tomasson, MD",
        "Shashikant Kulkarni, PhD, FACMG"
    ],
    "author_dict_list": [
        {
            "author_name": "Vishwanathan Hucthagowder, PhD",
            "author_affiliations": [
                "Department of pathology and immunology, Washington University school of medicine, Saint Louis, MO, USA, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Chelsea D. Mullins, BSci",
            "author_affiliations": [
                "Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rekha Meyer, PhD",
            "author_affiliations": [
                "Pathology and Immunology, Washington University school of medicine, Saint Louis, MO, USA, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rakesh Nagarajan, MD, PhD",
            "author_affiliations": [
                "Department of Pathology and Immunology, Siteman Cancer Center, Washington University, St. Louis, MO, USA, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "John F. DiPersio, MD, PhD",
            "author_affiliations": [
                "Department of Medicine, Division of Oncology, Siteman Cancer Center, Washington University, St. Louis, MO, USA, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ravi Vij, MBBS, MD",
            "author_affiliations": [
                "Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael H. Tomasson, MD",
            "author_affiliations": [
                "Department of Medicine, Siteman Cancer Center, Washington University, Saint Louis, MO, USA, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shashikant Kulkarni, PhD, FACMG",
            "author_affiliations": [
                "Dept. of Pathology and Immunology, Washington Univ. School of Med., Saint Louis, MO, USA"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-17T04:08:32",
    "is_scraped": "1"
}